PRISM Consortium Projects (IMI-funded)
Schizophrenia, Alzheimer's Disease, Major Depressive Disorder (for biomarker stratification)
ResearchActive
Key Facts
Indication
Schizophrenia, Alzheimer's Disease, Major Depressive Disorder (for biomarker stratification)
Phase
Research
Status
Active
Company
About P1vital
P1vital operates at the intersection of neuroscience research and digital health, providing technology-enabled solutions for CNS clinical trials. Its core offerings include a configurable eCOA platform for patient-reported outcomes and a library of pre-validated digital cognitive and behavioral tasks used as objective biomarkers. The company leverages over 20 years of scientific expertise to help pharmaceutical sponsors optimize trial design, enrich study populations, and make more informed drug development decisions, particularly in psychiatry and neurology.
View full company profile